Other substances

Bazedoxifene

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

 

Supporting references

Link Tested on Impact factor Notes Publication date
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate
Preprint 		Calu-3 human airway epithelial cells

higher IC50 value in Calu-3 cells than VERO E6 cells

 May/12/2020

AI-suggested references

Link Publication date
Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality.
Sep/03/2020
Export (.csv)